Reduced number of striatal neurons expressing preprosomatostatin mRNA in rats with oral dyskinesias after long-term haloperidol administration

被引:13
作者
Andreassen, OA
Finsen, B
Ostergaard, K
West, MJ
Jorgensen, HA
机构
[1] Univ Bergen, Dept Physiol, N-5009 Bergen, Norway
[2] Odense Univ, Dept Anat & Cell Biol, Odense, Denmark
[3] Univ Aarhus, Dept Neurobiol, DK-8200 Aarhus, Denmark
[4] Univ Bergen, Dept Psychiat, Sandviken Hosp, Bergen, Norway
关键词
neuroleptics; neuropeptides; stereology; densitometry; vacuous chewing movements; tardive dyskinesia;
D O I
10.1016/S0304-3940(99)00939-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neuroleptic-induced oral dyskinesia in rats, a putative analogue to human tardive dyskinesia, may be due to degeneration within the striatum. Using unbiased stereological methods, a decreased number of striatal neurons expressing preprosomatostatin mRNA was observed only in rats that developed pronounced oral dyskinesias after 30 weeks of haloperidol administration. The amount of preprosomatostatin mRNA in each striatal neuron, measured in terms of optical densities of individual neurons, was not affected by haloperidol. A tendency toward a reduction in the number of NADPH-diaphorase positive neurons was observed in rats receiving haloperidol. These results indicate that the mechanism by which neuroleptics induce oral dyskinesias in rats, and perhaps tardive dyskinesia in humans, involves a functional disruption and possibly damage of a subpopulation of interneurons in the striatum. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:21 / 24
页数:4
相关论文
共 23 条
[1]   The relationship between oral dyskinesias produced by long-term haloperidol treatment, the density of striatal preproenkephalin messenger RNA and enkephalin peptide, and the number of striatal neurons expressing preproenkephalin messenger RNA in rats [J].
Andreassen, OA ;
Finsen, B ;
Ostergaard, K ;
Sorensen, JC ;
West, MJ ;
Jorgensen, HA .
NEUROSCIENCE, 1999, 88 (01) :27-35
[2]   GM1 GANGLIOSIDE ATTENUATES THE DEVELOPMENT OF VACUOUS CHEWING MOVEMENTS INDUCED BY LONG-TERM HALOPERIDOL TREATMENT OF RATS [J].
ANDREASSEN, OA ;
JORGENSEN, HA .
PSYCHOPHARMACOLOGY, 1994, 116 (04) :517-522
[3]   Oral dyskinesias and striatal lesions in rats after long-term co-treatment with haloperidol and 3-nitropropionic acid [J].
Andreassen, OA ;
Ferrante, RJ ;
Beal, MF ;
Jorgensen, HA .
NEUROSCIENCE, 1998, 87 (03) :639-648
[4]   Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats [J].
Andreassen, OA ;
Aamo, TO ;
Jorgensen, HA .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (04) :751-757
[5]   DOPAMINERGIC-D1 AND DOPAMINERGIC-D2 RECEPTOR ANTAGONISTS DECREASE PROSOMATOSTATIN MESSENGER-RNA EXPRESSION IN RAT STRIATUM [J].
AUGOOD, SJ ;
KIYAMA, H ;
FAULL, RLM ;
EMSON, PC .
NEUROSCIENCE, 1991, 44 (01) :35-44
[6]  
Barak Y, 1998, Ann Clin Psychiatry, V10, P101, DOI 10.3109/10401239809148942
[7]   EFFECTS OF NEUROLEPTIC DRUGS ON BRAIN SOMATOSTATIN-LIKE-IMMUNOREACTIVITY [J].
BEAL, MF ;
MARTIN, JB .
NEUROSCIENCE LETTERS, 1984, 47 (02) :125-130
[8]   Oxidative stress-resistant cells are protected against haloperidol toxicity [J].
Behl, C ;
Lezoualch, F ;
Widmann, M ;
Rupprecht, R ;
Holsboer, F .
BRAIN RESEARCH, 1996, 717 (1-2) :193-195
[9]   NEUROLEPTIC MEDICATIONS INHIBIT COMPLEX-I OF THE ELECTRON-TRANSPORT CHAIN [J].
BURKHARDT, C ;
KELLY, JP ;
LIM, YH ;
FILLEY, CM ;
PARKER, WD .
ANNALS OF NEUROLOGY, 1993, 33 (05) :512-517
[10]   CHANGES IN DOPAMINE-MEDIATED BEHAVIOR DURING ONE YEARS NEUROLEPTIC ADMINISTRATION [J].
CLOW, A ;
JENNER, P ;
MARSDEN, CD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 57 (04) :365-375